Topical henna for capecitabine induced hand-foot syndrome

被引：36
作者：
Yucel, Idris [1 ]
Guzin, Gonullu [1 ]
机构：
[1] Ondokuz Mayis Univ, Sch Med, Dept Med Oncol, TR-55139 Kurupelit, Turkey
来源：
INVESTIGATIONAL NEW DRUGS | 2008年 / 26卷 / 02期
关键词：
henna; capecitabine; hand-foot;
D O I：
10.1007/s10637-007-9082-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Capecitabine is a chemotherapeutic drug for use in cancers. Hand-foot syndrome (HFS) is side effect of capecitabine which can lead the cessation of the therapy or dose reduction. Henna (Lawsonia inermis) is a traditionally used plant of Middle-East that is applied on hands and feet. Some of cancer patients in capecitabine treatment who developed HFS, we recommended to apply henna. In these patients, six patients were grade 3 HFS and four were grade 2 HFS. Complete response (CR) were seen in four of grade 3 HFS and all of grade 2; two grade 3 HFS improved to grade 1. So far, in the chemotherapy, there was no need of dose reduction and also no side effect of henna seen. Clinical improvement in these patients may relate to anti-inflammatory, antipyretic and analgesic effects of henna. Prospective studies are needed to show this therapeutic effect of henna.
引用
收藏
页码：189 / 192
页数：4
相关论文
共 50 条
  • [31] Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer
    Lin, Shaoyan
    Yue, Jian
    Guan, Xiuwen
    Yuan, Peng
    Wang, Jiayu
    Luo, Yang
    Fan, Ying
    Cai, Ruigang
    Li, Qiao
    Chen, Shanshan
    Zhang, Pin
    Li, Qing
    Ma, Fei
    Xu, Binghe
    CANCER COMMUNICATIONS, 2019, 39 (01):
  • [32] Hand-foot syndrome caused by capecitabine: incidence, risk factors and the role of dermatological evaluation
    de Queiroz, Marina Vieira Rodrigues
    de Medeiros, Ana Carolina Tardin Rodrigues
    Toledo, Sarah Pires
    Sarmenghi, Karina Demoner de Abreu
    de Vasconcellos, Vitor Fiorin
    ECANCERMEDICALSCIENCE, 2022, 16
  • [33] Efficacy of topical Lawsonia inermis L. (Henna) hydrogel in fluorouracil-induced hand-foot syndrome: a pilot randomized double-blind placebo-controlled clinical trial
    Mohajerani, Razieh
    Shahi, Farhad
    Jafariazar, Zahra
    Afshar, Minoo
    CUTANEOUS AND OCULAR TOXICOLOGY, 2021, 40 (03) : 257 - 262
  • [34] An unusual case of capecitabine hyperpigmentation: Is hyperpigmentation a part of hand-foot syndrome or a separate entity
    Vasudevan, Biju
    INDIAN JOURNAL OF PHARMACOLOGY, 2010, 42 (05) : 326 - 328
  • [35] Pharmaceutical and clinical studies of celecoxib topical hydrogel for management of chemotherapy-induced hand-foot syndrome
    Shayeganmehr, Delaram
    Ramezannia, Fatemeh
    Gharib, Behrooz
    Rezaeilaal, Azin
    Shahi, Farhad
    Jafariazar, Zahra
    Afshar, Minoo
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 (07) : 1571 - 1581
  • [36] Proton Pump Inhibitors Ameliorate Capecitabine-induced Hand-Foot Syndrome in Patients With Breast Cancer: A Retrospective Study
    Takemura, Miho
    Ikemura, Kenji
    Yoshinami, Tetsuhiro
    Toyozumi, Yuji
    Shintani, Takuya
    Ueda, Mikiko
    Shimazu, Kenzo
    Okuda, Masahiro
    ANTICANCER RESEARCH, 2022, 42 (05) : 2591 - 2598
  • [37] Significant Association between Hand-Foot Syndrome and Efficacy of Capecitabine in Patients with Metastatic Breast Cancer
    Azuma, Yuichiro
    Hata, Kojiro
    Sai, Kimie
    Udagawa, Ryoko
    Hirakawa, Akihiro
    Tohkin, Masahiro
    Ryushima, Yasuaki
    Makino, Yoshinori
    Yokote, Nobuaki
    Morikawa, Norifumi
    Fujiwara, Yasuhiro
    Saito, Yoshiro
    Yamamoto, Hiroshi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (05) : 717 - 724
  • [38] Hemoglobin Value Is the Most Important Factor in the Development of Hand-Foot Syndrome under the Capecitabine Regimen
    Naito, Masahito
    Yamamoto, Tomoya
    Hara, Shinsuke
    Shimamoto, Chikao
    Miwa, Yoshihiro
    CHEMOTHERAPY, 2017, 62 (01) : 23 - 29
  • [39] The concurrence of subacute cutaneous lupus erythematosus and hand-foot syndrome in a patient undergoing capecitabine chemotherapy
    Li, Zhiming
    Jiang, Nanyan
    Xu, Yunsheng
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 (01) : E14 - E16
  • [40] Capecitabine-induced hand-foot syndrome does not emerge in the complex regional pain syndrome-affected limb: A case report
    Inoue, Reo
    Abe, Hiroaki
    Konishi, Mitsuru
    Tsuchida, Rikuhei
    Edamura, Tatsuma
    Sumitani, Masahiko
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 15 (06)
12345